These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29381861)

  • 1. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
    Liang Z; Li QX
    ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors.
    De Simone A; Fiori J; Naldi M; D'Urzo A; Tumiatti V; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2017 Sep; 144():159-166. PubMed ID: 28268049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer's disease.
    Yan N; Xie F; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    Bioorg Chem; 2023 Sep; 138():106663. PubMed ID: 37329814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
    Yang Z; Liu H; Pan B; He F; Pan Z
    Org Biomol Chem; 2018 Jun; 16(22):4127-4140. PubMed ID: 29781013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of thieno[3,2-
    Yan N; Shi XL; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1724-1736. PubMed ID: 35698879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
    Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
    Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
    Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
    Cheng Z; Han T; Yao J; Wang K; Dong X; Yu F; Huang H; Han M; Liao Q; He S; Lyu W; Li Q
    Eur J Med Chem; 2024 Feb; 265():116065. PubMed ID: 38160617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration.
    Zhou Q; Li S; Li M; Ke D; Wang Q; Yang Y; Liu GP; Wang XC; Liu E; Wang JZ
    EBioMedicine; 2022 Apr; 78():103970. PubMed ID: 35339896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
    Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition.
    Liang Z; Zhang B; Su WW; Williams PG; Li QX
    ACS Chem Neurosci; 2016 Jul; 7(7):912-23. PubMed ID: 27213824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-
    Hartz RA; Ahuja VT; Sivaprakasam P; Xiao H; Krause CM; Clarke WJ; Kish K; Lewis H; Szapiel N; Ravirala R; Mutalik S; Nakmode D; Shah D; Burton CR; Macor JE; Dubowchik GM
    J Med Chem; 2023 Mar; 66(6):4231-4252. PubMed ID: 36950863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
    Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.